Will the total number of global human deaths attributed to mosquito-borne diseases fall by more than 20% by the end of 2030?

The Battle Against the Vector

Mosquito-borne diseases, primarily malaria, cause hundreds of thousands of deaths annually (WHO, simulated late 2025 context). However, a convergence of high-impact interventions is coming online: Next-generation malaria vaccines (R21) are being deployed rapidly, and genetic engineering (like gene drive technology using CRISPR) is being piloted to control mosquito populations. A 20% reduction in total deaths before 2030 is ambitious but achievable. The slight 'Yes' majority reflects the confidence that the synergistic effect of these technologies—vaccines providing immediate protection and genetic methods offering long-term population control—will generate a significant impact on global mortality in this short timeframe.